Eming, S. A. (2018). Current pathophysiological developments in fibrosing diseases: insights into novel treatment concepts. Hautarzt, 69 (11). S. 885 - 892. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1173

Full text not available from this repository.

Abstract

Fibrosis is acommon symptom of avariety of skin disorders of diverse entity. The cellular and molecular pathophysiology of fibrosis development is unresolved and current treatment options are not sufficient. Tissue fibrosis leads to increased tissue stiffness, impaired organ function, decline of quality of life and ultimately increased morbidity and mortality. Epidemiologic studies indicate that nearly 45% of all deaths in the western world are associated with tissue fibrosis in diverse organs. Only few recently approved treatment options specifically target the process of fibrogenesis. The development of novel and efficient therapies is urgently needed, and at the same time provides amajor challenge but also an opportunity to contribute to the advancement of this unresolved medical problem. This article highlights recent insights in the developments on tissue fibrosis with afocus on immunoregulatory mechanisms.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Eming, S. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-168152
DOI: 10.1007/s00105-018-4256-9
Journal or Publication Title: Hautarzt
Volume: 69
Number: 11
Page Range: S. 885 - 892
Date: 2018
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1432-1173
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
REPAIR; MACROPHAGES; MECHANISMS; CELLS; HEARTMultiple languages
DermatologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/16815

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item